Read more
12:18 · 26 January 2026

Economic calendar: Ifo data from Germany and retail sales in Poland đź’ˇWall Street earnings calendarâť—

European stocks are starting Monday's trading with moderate gains, although it is worth bearing in mind that trading immediately after the start of the session can be very volatile, so it may take more time for a specific trend to emerge. At the moment, however, the German DAX is up 0.11% on the cash market, the European Euro Stoxx 50 is up 0.12%, and the Polish WIG20 is up 0.14%.

Today's session itself will not be rich in macro data releases that could radically change investor sentiment. We will have to wait until at least tomorrow for those. However, today will see the publication of IFO sentiment data from Germany and a report from Poland on retail sales. A little later, as Wall Street approaches its opening, we will learn the values of changes in durable goods orders.

Today's session will most likely be driven by weekly rebalancing, any financial data from major companies, and possible geopolitical events.

Detailed schedule below:

Today's session calendar. Source: XTB

Results calendar for this week. Source: XTB

10 April 2026, 21:59

Daily summary: Nervous anticipation, SaaS sell-off and weak macro data

10 April 2026, 21:26

“SaaS-pocalypse” continued

10 April 2026, 20:38

Three Markets to Watch in the Week Ahead (10.04.2026)

10 April 2026, 18:20

BREAKING: University of Michigan - weaker consument, higher inflation

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.